Your only mesothelioma clinical trials news source! Click on each item to read full story.   Aduro Announces Poster Presentations of Phase 2 Pancreatic Cancer and Phase 1B Mesothelioma Clinical Trials at ASCO read story Aduro BioTech, Inc. announces two poster presentations at the upcoming American Society of Clinical Oncology annual meeting in Chicago. Dr. Raffit Hassan, Head of the Solid Tumor Immunotherapy Section at the Laboratory of Molecular Biology at the National Cancer Institute, will present data from Aduro’s Phase 1B clinical trial in patients with malignant pleural mesothelioma .   Verastem to Present at the 2013 ASCO Annual Meeting read story Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced that members of the research and development team will present the clinical design for an ongoing study of VS-6063 and preclinical data on the dual PI3K/mTOR inhibitor VS-5584 at the American Society of Clinical Oncology Annual Meeting being held May 31 – June 4 ...   Verastem Reports First Quarter 2013 Financial and Corporate Results read story Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, today reported financial results for the qu   New Antibody Could Boost Chemotherapy for Mesothelioma, According to Surviving Mesothelioma read story Surviving Mesothelioma Reports that a study in Italy contains some potential good news for mesothelioma patients. (PRWeb May 09, 2013) Read the full story at http://www.prweb.com/releases/2013/5/prweb10716176.htm   Jack Green Joins Verastem as Chief Financial Officer read story Verastem, Inc., focused on discovering and developing drugs to treat cancer by the targeted killing of cancer stem cells, announced the appointment of John “Jack” Green as Chief Financial Officer.   Trusting God through trials read story Terminal cancer patient Tim Hermetz maintains a positive attitude inspiring others while enduring the storms of life, fighting a grim prognosis and his dad’s sudden death.   Verastem Hires a CFO read story Biotech has an ambitious trials program coming up, and now has a chief financial officer to help keep track of spending on it.           ImmunoGen, Inc. Reports Third Quarter Fiscal Year 2013 Financial Results and Provides Quarterly Update read story ImmunoGen, Inc. , a biotechnology company that develops anticancer therapeutics using its Targeted Antibody Payload antibody-drug conjugate technology, to   Press Release read story Aduro BioTech Inc. Posted on:25 Apr 13 In first graph last sentence of release dated April 22 2013 organization name should read:Â Melanoma Research Alliance (sted Melanoma Research Foundation).